[HTML][HTML] Therapeutic agents for the treatment of temporomandibular joint disorders: progress and perspective

M Wu, J Cai, Y Yu, S Hu, Y Wang, M Wu - Frontiers in Pharmacology, 2021 - frontiersin.org
Temporomandibular joint disorders (TMD) are a common health condition caused by the
structural or functional disorders of masticatory muscles and the temporomandibular joint …

[HTML][HTML] Psoriatic Arthritis Involving TMJ: A Review on Pathogenesis and Consideration on Eventual Gender Differences

S Bernardi, L Memè, C Belfioretti, F Bambini… - Dentistry Journal, 2024 - mdpi.com
Psoriatic arthritis is defined as chronic inflammatory arthritis associated with psoriasis. The
current data regarding gender differences in clinical manifestation and therapeutic outcomes …

[HTML][HTML] Gender difference in associations between chronic temporomandibular disorders and general quality of life in Koreans: a cross-sectional study

TY Kim, JS Shin, J Lee, YJ Lee, M Kim, Y Ahn, KB Park… - PloS one, 2015 - journals.plos.org
Background Chronic temporomandibular disorder (TMD) is known to have strong
correlations with psychological factors and to display gender disparity. However, while …

[HTML][HTML] Disrupted spontaneous neural activity and its interaction with pain and emotion in temporomandibular disorders

XF Chen, P He, KH Xu, YH Jin, Y Chen… - Frontiers in …, 2022 - frontiersin.org
Background and Purpose Temporomandibular disorders (TMD), especially pain-related
TMD, are closely related to social and psychological factors. We aimed to measure changes …

[HTML][HTML] Nerve growth factor and glutamate increase the density and expression of substance P-containing nerve fibers in healthy human masseter muscles

AM Alhilou, A Shimada, CI Svensson, P Svensson… - Scientific Reports, 2021 - nature.com
Nocifensive behavior induced by injection of glutamate or nerve growth factor (NGF) into rats
masseter muscle is mediated, in part, through the activation of peripheral NMDA receptors …

Biomarkers in temporomandibular disorder and trigeminal neuralgia: A conceptual framework for understanding chronic pain

TL Doshi, DR Nixdorf, CM Campbell… - Canadian Journal of …, 2020 - Taylor & Francis
In this review, we will explore the use of biomarkers in chronic pain, using the examples of
two prototypical facial pain conditions: trigeminal neuralgia and temporomandibular …

[HTML][HTML] The intraperitoneal ondansetron for postoperative pain management following laparoscopic cholecystectomy: A proof-of-concept, double-blind, placebo …

DH Abdelaziz, S Boraii, E Cheema, MH Elnaem… - Biomedicine & …, 2021 - Elsevier
Background Pain after laparoscopic cholecystectomy remains a major challenge.
Ondansetron blocks sodium channels and may have local anesthetic properties. Aims To …

[HTML][HTML] Contribution of central sensitization to stress-induced spreading hyperalgesia in rats with orofacial inflammation

JH Li, JL Yang, SQ Wei, ZL Li, AA Collins, M Zou, F Wei… - Molecular Brain, 2020 - Springer
Temporomandibular disorder (TMD) is commonly comorbid with fibromyalgia syndrome
(FMS). The incidence of these pain conditions is prevalent in women and prone to mental …

Monoclonal antibodies for chronic pain: a practical review of mechanisms and clinical applications

JF Yeh, A Akinci, M Al Shaker, MH Chang… - Molecular …, 2017 - journals.sagepub.com
Context Monoclonal antibodies are being investigated for chronic pain to overcome the
shortcomings of current treatment options. Objective To provide a practical overview of …

[HTML][HTML] Targeted therapy for orofacial pain: a novel perspective for precision medicine

S Raman, D Ikutame, K Okura, Y Matsuka - Journal of Personalized …, 2023 - mdpi.com
Orofacial pain (OFP) is a dental specialty that includes the diagnosis, management and
treatment of disorders of the jaw, mouth, face, head and neck. Evidence-based …